Author:
Okazaki Atsushi,Tamaki Tomoaki,Uki Akiyoshi,Maruno Hirotaka,Kurosaki Hiromasa,Oriuchi Noboru,Higuchi Tetsuya,Izuta Masato,Kojima Rieko,Kato Yoshio
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference13 articles.
1. Kubik-Huch RA, Dorffler W, von Schulthess GK, Marincek B, Kochli OR, Seifert B, et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.Eur Radiol 2000; 10:761–767.
2. Yen RF, Sun SS, Shen YY, Changlai SP, Kao A. Whole body positron emission tomography with18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.Anticancer Res 2001; 21:3691–3694.
3. Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer.AJR Am J Roentgenol 2001; 176:1449–1454.
4. Torizuka T, Nobezawa S, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose.Eur J Nucl Med Mol Imaging 2002; 29:797–803.
5. Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.Gynecol Oncol 2001; 83:310–315.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献